Primary FDA-Approved Indications
Hydroxyzine (Atarax, Vistaril) is a first-generation H1-receptor antagonist with antihistaminic, anxiolytic, and sedative properties. FDA-approved for pruritus, anxiety, and pre/post-operative sedation in pediatrics. Recent evidence raises concerns about repeated use in children under 5 years. Maximum dose: 2 mg/kg/day in children ≤40 kg due to cardiac risks.
Pruritus due to allergic conditions
FDA ApprovedEffective for acute urticaria, atopic dermatitis flares. Consider cetirizine for chronic use due to better safety profile.
Efficacy Data
Treatment Duration
Standard: As needed for acute symptoms (Range: Single dose to 7 days)
Evidence Sources
Pre-operative and post-operative sedation
FDA ApprovedProvides anxiolysis and sedation. IM route preferred in uncooperative patients.